A simple tool to help you differentiate between ADHD and the most common overlapping comorbidities in children
Enter your full name and email and you will receive your complimentary download today
-Irene Koolwijk, MD, et al
While a certain proportion of children with ADHD express symptoms of ADHD alone (often described by your peers as “simple ADHD”), we now know that this is overwhelmingly the exception rather than the norm.1-3
Growing evidence supports a new paradigm of complex ADHD that underscores the need for effective and proactive management of the disease early in childhood.4-7
Growing evidence support a paradigm of ADHD as a complex disorder, with neurobiologic vulnerabilities, and various associated comorbidities.1-4
ADHD is now conceived as a complex genetic trait with a heterogeneous presentation based upon a phenotype ranging from mildly to severely affected.8
Genetics has also been shown to contribute to the onset, persistence, and remission of ADHD9—and may account, in part, for the co-occurrence of ADHD with emotional dysregulation.2
Comorbidities such as depression, anxiety disorders, and conduct disorders tend to develop later.2
Such sequencing of symptoms has led some to suggest that executive functioning deficits in individuals with ADHD may leave them more vulnerable to future psychiatric illness.2 This again underscores the need for proactive and effective treatment options early in the ADHD disease process.
References: 1. Koolwijk I, Stein DS, Chan E, Powell C, Driscoll K, Barbaresi WJ. “Complex” attention-deficit hyperactivity disorder, more norm than exception? Diagnoses and comorbidities in a developmental clinic. J Dev Behav Pediatr. 2014;35:591–597. 2. Brown TE. Developmental complexities of attentional disorders. In: Brown TE, ed. ADHD Comorbidities: Handbook for ADHD Complications in Children and Adults. Arlington, VA: American Psychiatric Publishing Inc; 2009:3–23. 3. Shaw P, Polanczyk GV. Combining epidemiological and neurobiological perspectives to characterize the lifetime trajectories of ADHD. Eur Child Adolesc Psychiatry. 2017;26(2):139-141. 4. Banaschewski T, Becker K, Dopfner M, Holtmann M, Rosler M, Romanos M. Attention-deficit/hyperactivity disorder. Dtsch Arztebl Int. 2017;114(9):149–159. 5. Hervas A, de Santos T, Quintero J, et al. Delphi consensus on attention deficit hyperactivity disorder (ADHD): evaluation by a panel of experts. Actas Esp Psiquiatr. 2016;44(6):231-243. 6. Jensen CM, Steinhausen H-C. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord. 2015;7(1):27-38. 7. Reale L, Bartoli B, Cartabia M, et al. Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. Eur Child Adolesc Psychiatry. 2017;26(12):1443-1457. 8. Acosta MT, Arcos-Burgos M, Muenke M. Attention deficit/hyperactivity disorder (ADHD): complex phenotype, simple genotype? Genet Med. 2004;6(1):1–15. 9. Faraone SV, Asherson P, Banaschewski T, et al. Attention deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015:1:1–23.